Close
APE 2026

Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Siemens Healthineers Divesting Diagnostics Division Possible

Siemens Healthineers divesting diagnostics division by 2030 or spinning...

Siemens to Deconsolidate Stake in Siemens...

Siemens has gone on to announce its plans to...

Renewed Collaboration Between NHS & ABPI...

The Welsh NHS Confederation and the Association of the...

Latest Developments in Health and Care...

As 2025 draws to a close, it is time...

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced Calypso’s real-time traacking technology is included in 36 scientific presentations and posters at the 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), now underway at McCormick Place in Chicago. These studies highlight the potential applications of the technology and the benefits associated with real-time tracking of the prostate, for which the Calypso® System is currently commercially available.

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced Calypso’s real-time tracking technology is included in 36 scientific presentations and posters at the 51st Annual Meeting of the American Society for Therapeutic Radiation Oncology (ASTRO), now underway at McCormick Place in Chicago. These studies highlight the potential applications of the technology and the benefits associated with real-time tracking of the prostate, for which the Calypso® System is currently commercially available.

The topics of prostate-related studies include prostate SBRT, prone prostate treatment, workflow efficiency, and dose escalation.  Studies of investigational applications, such as high-velocity pancreatic and lung tumors, will also be presented. Calypso is exhibiting during this conference at booth 1231 and Calypso Systems will also be displayed in collaboration with Siemens Healthcare at booth 1829 and Varian Medical Systems at booth 2229.

According to the American Cancer Society, prostate cancer is the leading cancer in men in the United States with 192,000 new cases diagnosed each year. The prostate is also the most common target for radiation therapy in the body. Since the radiation beam is more precisely focused on the tumor target, Calypso’s technology allows clinicians to more tightly contour the radiation dose to the prostate and minimize unwanted dose to adjacent healthy tissues.

Latest stories

Related stories

Siemens Healthineers Divesting Diagnostics Division Possible

Siemens Healthineers divesting diagnostics division by 2030 or spinning...

Siemens to Deconsolidate Stake in Siemens Healthineers

Siemens has gone on to announce its plans to...

Renewed Collaboration Between NHS & ABPI for Better Outcomes

The Welsh NHS Confederation and the Association of the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »